E O Cheremukhina

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM To retrospectively analyze the efficacy and safety of sildenafil (Sf) in patients with systemic sclerosis (SS). SUBJECTS AND RESULTS Sf was used in 16 patients (including 14 women) aged 20-66 years (mean 48.6 +/- 14.6 years; median 51.5 years) with SS of a duration of 2 months to 27 years (mean 8.8 +/- 7.3 years; median 6.5 years). The indications for(More)
  • 1